首頁 > 市場調查報告書 > 醫療設備

病患監測

全球腦血氧飽和度監測市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

市場調查報告書

商品編碼

1377823

全球腦血氧飽和度監測市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

Global Cerebral Oximetry Monitoring Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年09月01日 | 出版商:

Value Market Research | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球腦血氧監測市場需求預計將從 2022 年的 203.21 萬美元達到 2030 年近 384.57 萬美元的市場規模，2023-2030 年研究期間CAGR為 8.3%。

腦血氧飽和度監測是一種測量和監測大腦中氧氣水平的醫療技術。它是一種非侵入性方法，可連續或定期評估腦組織中的氧飽和度（氧氣水平）。這項技術在重症監護、手術和各種醫療環境中特別有價值，因為在這些環境中維持最佳的腦部氧合至關重要。

市場動態：

在強調即時腦氧飽和度評估在醫療保健環境中重要性的多種因素的推動下，腦血氧飽和度監測市場正在不斷成長。醫療保健提供者越來越認知到監測腦部氧合對於預防腦損傷和提高病人安全的重要性。腦血氧飽和技術在手術中有著重要的應用，特別是在心臟和神經外科等複雜手術中，維持最佳的腦部氧合對於預防術後併發症至關重要。麻醉管理受益於這項技術，因為它允許麻醉師在手術過程中進行精確調整，最大限度地降低缺氧風險。重症監護病房 (ICU) 正在採用腦血氧飽和度監測重症患者，以便及時採取干涉措施並獲得更好的結果。監測設備的技術進步進一步擴大了其應用範圍，使監測更加準確和方便用戶使用。隨著全球人口老化和神經系統疾病發病率的上升，對監測解決方案的需求正在穩步增加。支持腦血氧測定法益處的臨床證據、監管支持以及遠端監測技術的整合都有助於市場的擴張。最終，腦血氧飽和度監測在提高病患安全、減少併發症和改善各種醫療機構的治療結果方面發揮著至關重要的作用。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球腦血氧飽和度監測市場的各個細分市場進行了包容性評估。腦血氧飽和度監測產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲腦血氧監測市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。腦血氧監測市場的主要參與者包括 Masimo、Medtronic、Edwards Lifesciences Corporation、Nonin、ISS, Inc.、Hamamatsu Photonics KK、Mespere LifeSciences、GE Healthcare、Terumo Cardioangio Systems Corporation。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：腦血氧監測公司的競爭格局

腦血氧監測市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Masimo

公司簡介
公司收入
產品
最近的發展

Medtronic

公司簡介
公司收入
產品
最近的發展

Edwards Lifesciences Corporation

公司簡介
公司收入
產品
最近的發展

Nonin

公司簡介
公司收入
產品
最近的發展

ISS Inc.

公司簡介
公司收入
產品
最近的發展

Hamamatsu Photonics KK

公司簡介
公司收入
產品
最近的發展

Mespere LifeSciences

公司簡介
公司收入
產品
最近的發展

GE Healthcare

公司簡介
公司收入
產品
最近的發展

Terumo Cardiovascular Systems Corporation

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112112198

The global demand for Cerebral Oximetry Monitoring Market is presumed to reach the market size of nearly USD 384.57 MN by 2030 from USD 203.21 MN in 2022 with a CAGR of 8.3% under the study period 2023 - 2030.

Cerebral oximetry monitoring is a medical technique that measures and monitors the levels of oxygen in the brain. It is a non-invasive method that provides continuous or periodic assessments of oxygen saturation (oxygen levels) in the cerebral tissue. This technology is particularly valuable in critical care, surgery, and various medical settings where maintaining optimal brain oxygenation is essential.

MARKET DYNAMICS:

The Cerebral oximetry monitoring market is on the rise, driven by a confluence of factors that emphasize the importance of real-time brain oxygenation assessment in healthcare settings. Healthcare providers increasingly recognize the significance of monitoring cerebral oxygenation to prevent brain injury and enhance patient safety. Cerebral oximetry technology finds significant application in surgery, particularly in complex procedures like cardiac and neurosurgery, where maintaining optimal brain oxygenation is critical to prevent postoperative complications. Anesthesia management benefits from this technology, as it allows anesthesiologists to make precise adjustments during surgery, minimizing the risk of hypoxia. Intensive care units (ICUs) are adopting cerebral oximetry to monitor critically ill patients, enabling timely interventions and better outcomes. Technological advancements in monitoring devices are further expanding their adoption, making monitoring more accurate and user-friendly. With the global population aging and the incidence of neurological disorders on the rise, the need for monitoring solutions is steadily increasing. Clinical evidence supporting the benefits of cerebral oximetry, regulatory support, and the integration of remote monitoring technologies all contribute to the market's expansion. Ultimately, cerebral oximetry monitoring plays a vital role in enhancing patient safety, reducing complications, and improving outcomes in various healthcare settings.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cerebral oximetry monitoring. The growth and trends of cerebral oximetry monitoring industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cerebral oximetry monitoring market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Cardiac Surgery
Vascular Surgery
Others

By Age Group

Pediatric
Adult

By End-Use

Hospitals & Clinics
Ambulatory Surgical Centers
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cerebral Oximetry Monitoring market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cerebral Oximetry Monitoring market include Masimo, Medtronic, Edwards Lifesciences Corporation, Nonin, ISS, Inc., Hamamatsu Photonics K.K., Mespere LifeSciences, GE Healthcare, Terumo Cardiovascular Systems Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CEREBRAL OXIMETRY MONITORING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Age Group
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CEREBRAL OXIMETRY MONITORING MARKET ANALYSIS BY APPLICATION

5.1 Overview by Application
5.2 Historical and Forecast Data
5.3 Analysis by Application
5.4 Cardiac Surgery Historic and Forecast Sales by Regions
5.5 Vascular Surgery Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL CEREBRAL OXIMETRY MONITORING MARKET ANALYSIS BY AGE GROUP

6.1 Overview by Age Group
6.2 Historical and Forecast Data
6.3 Analysis by Age Group
6.4 Pediatric Historic and Forecast Sales by Regions
6.5 Adult Historic and Forecast Sales by Regions

7 . GLOBAL CEREBRAL OXIMETRY MONITORING MARKET ANALYSIS BY END-USE

7.1 Overview by End-use
7.2 Historical and Forecast Data
7.3 Analysis by End-use
7.4 Hospitals & Clinics Historic and Forecast Sales by Regions
7.5 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL CEREBRAL OXIMETRY MONITORING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CEREBRAL OXIMETRY MONITORING COMPANIES

9.1. Cerebral Oximetry Monitoring Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF CEREBRAL OXIMETRY MONITORING INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Masimo
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Medtronic
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Edwards Lifesciences Corporation
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Nonin
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. ISS Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Hamamatsu Photonics K.K.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Mespere LifeSciences
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. GE Healthcare
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Terumo Cardiovascular Systems Corporation
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments